breast cancer research
Over the past decade, the phrases ‘BRCA 1’ and ‘BRCA 2’ went mainstream as genetic testing to assess breast cancer risk became common. But, now, doctors are telling patients whose tests were negative to get retested.
A North Texas hospital is performing groundbreaking breast cancer research. Doctors are using cutting edge medical technology to customize treatment.
A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.
For eight years, D’Lyn Biggs has walked the Susan G. Komen 3-Day. She’s logged more than 400 miles, and along with a team of supporters has raised more than $800,000 for the cause.
This month many people are thinking ‘pink’ for breast cancer awareness, but for survivors, the fight is anything but pretty. Now local survivors have taken to the internet to paint another picture of breast cancer.
Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group.
The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.